Abstract
Biofilms are very specialized but at the same time very widespread form of bacterial existence. Nowadays it is well understood that biofilms play significant role in many human infections. That is way recently a number of research project are concentrated in the development of different methods of biofim disruption and of prophylaxis of biofilm formation. The present article is concentrated on the possible use on N-acetylcysteine in the treatment of biofilm-associated respiratory infections.
-
1.
Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganism. Clin Microbiol Rev 2002; 15:167-93.
-
2.
Flemming H.C., Wingender J. The biofilm matrix. Nat Rev Microbiol 2010; 8:623-33.
-
3.
Vu B., Chen M., Crawford R.J., et al. Bacterial extracellular polysaccharides involved in biofilm formation. Molecules 2009; 14:2535-54.
-
4.
Pintucci J.P., Corno S., Garotta M. Biofilms and infections of the upper respiratory tract. Eur Rev Med Pharmacol Sci 2010; 14:683-90.
-
5.
Biofilm life cycle. Montana State University Center for Biofilm Engineering. Available at ULR: http://www.biofilm.montana.edu
-
6.
Aslam S., Darouiche R.O. Role of antibiofilm-antimicrobial agents in controlling device-related infections. Int J Artif Organs 2010; 34:752-8.
-
7.
Post J.C., Hiller N.L., Nistico L., et al. The role of biofilms in otolaryngologic infections: update 2007. Curr Opin Otolaryngol Head Neck Surg 2007; 15:347-51.
-
8.
Werthen M., Henriksson L, Jensen P.O., et al. An in vitro model of bacterial infections in wounds and other tissues. APMIS 2010; 118:156-64.
-
9.
Davies J.C., Bilton D. Bugs, biofilms, and resistance in cystic fibrosis. Respir Care 2009; 54:628-40.
-
10.
Hall-Stoodley L., Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol 2009; 11:1034-43.
-
11.
Palmer R.J., Stoodley P. Biofilms 2007: broadened horizons and new emphases. J Bacteroil 2007; 189:7948- 60.
-
12.
Rayner M.G., Zhang Y., Gorry M.C., et al. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA 1998; 279:296-9.
-
13.
Post J.C. Direct evidence of bacterial biofilms in otitis media. Laryngoscope 2001; 111:2083-94.
-
14.
Hall-Stoodley L., Hu F.Z., Gieseke A., et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006; 296:202-11.
-
15.
Cohen M., Kofonow J., Nayak J.V., et al. Biofilm in chronic rhinosinusitis: a review. Am J Rhinol Allergy 2009; 23:255-60.
-
16.
Foreman A., Psaltis A.J., Tan L.W., et al. Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Am J Rhinol Allergy 2009; 23:556-61.
-
17.
Kilty S.J., Desrosiers M.Y. The role of bacterial biofilms and the pathophysiology of chronic rhinosinusitis. Curr Allergy Asthma Rep 2008; 8:227-33.
-
18.
Al-Mazrou K.A., Al-Khattaf A.S. Adherent biofilms in adenotonsillar diseases in children. Arch Otolaryngol Head Neck Surg 2008; 134:20-3.
-
19.
Galli J., Calo L., Ardito F., et al. Biofilm formation by Haemophilus influenzae isolates from adenotonsil tissue samples, and its role in recurrent adenotonsillitis. Acta Otorhinolaringol Ital 2007; 27:134-8.
-
20.
O'Grady N., Alexander M., Dellenger E., et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2002; 35:1281-1307.
-
21.
Голуб А.В. Новые возможности профилактики инфекций области хирургического вмешательства. Clinical Microbiology and Antimicrobial Chemotherapy.2011; 13:56-66.
-
22.
Козлов Р.С., Голуб А.В. Катетер-ассоциированные инфекции кровотока: предупредить или лечить? Clinical Microbiology and Antimicrobial Chemotherapy.2010; 12:23- 30.
-
23.
Elliot T.S.J., Curran A. Effects of heparin and chlorbutol on bacterial colonization of intravascular cannulae in an in vitro model. J Hosp Infect 1989; 14:193-200.
-
24.
Smith A., Buchinsky F.J., Post J.C. Eradicating chronic ear, nose and throat infections: a systematically conducted literature review of advances in biofilm treatment. Otolaryngol Head Neck Surg 2011; 144:338-47.
-
25.
Gordon C.A., Hodges N., Marriott C. Use of slime dispersants to promote antibiotic penetration through the extracellular polisaccaride of mucoid Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991; 35:1258-60.
-
26.
Desrosiers M., Bendauah Z., Barbeau J. Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro. Am J Rhinol 2007; 21:149-53.
-
27.
Keays T., Ferris W., Vandemheen K.L., et al. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations. J Cyst Fibros 2009; 8:122-7.
-
28.
Solares C.A., Barta P.S., Hall G.S., et al. Treatment of chronic rhinosinusitis exacerbations due to methicillinresistant Staphylococcus aureus with mupirocin irrigation. Am J Otolaryngol 2006; 27:161-5.
-
29.
Rodríguez-Martínezemail J.M., Ballesta S., Pascual A. Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms. Int J Antimicrob Agents 2007; 30:366-8.
-
30.
Singh R., Ray P., Das A., Sharma M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother 2010; 65:1955-8.
-
31.
Smith A.W. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev 2005; 29:1539-50.
-
32.
Moen M.D., Lyseng-Williamson K.A., Scott L.J. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs 2009; 69:361-92.
-
33.
Grassi C., De Benedetto F., Macchi A. Recent clinical evidence on the efficacy and safety of thiamphenicol glycinate acetylcysteinate and thiamphenicol glycinate. Proceedings of the 3rd International Symposium Nosocomial Infections Today; 2001 November 5–8; Venice, Itali.
-
34.
Riise G.C., Qvarfordt I., Larsson S., et al. Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro. Respiration 2000; 67:552-8.
-
35.
Macchi A., Ardito F., Marchese A., et al. Efficacy of N-acetylcisteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even if sustained by bacterial biofilms. J Chemother 2006; 18:507-13.
-
36.
Zhao T., Liu Y. N-acetylcysteine inhibit biofilm produced by Pseudomonas aeruginosa. BMC Microbiol 2010; 10:140.
-
37.
Perez-Giraldo C., Rodriguez-Benito A., Moran F.J., et al. Influence of N-acetylcysteine on formation of biofilm by Staphylococcus epidermidis. J Ant Chem 1997; 39:643-6.